Showcase Your Expertise, Drive Scientific Collaboration & Accelerate ALS Research
Despite recent failures, the ALS drug development landscape continues to pour money into ALS R&D services, marked by transformative investments and collaborations. Recent highlights include Dewpoint Therapeutics’ $480M partnership with Mitsubishi Tanabe Pharma to advance TDP-43 small-molecule therapies and Novo Nordisk’s equity investment in Eikonizo Therapeutics to develop their CNS-penetrant HDAC6 inhibitor. Meanwhile, Verge Genomics’ collaboration with Eli Lilly to pursue two validated ALS drug targets and Asha Therapeutics’ ALS Association grant for first-in-human trials reflect the dynamic momentum driving innovation.
The 4th ALS Drug Development Summit is your exclusive opportunity to align your organization with the brightest minds and most forward-thinking companies in the ALS ecosystem. This is where the deals are made, collaborations are forged, and science transforms into impactful therapies for ALS and FTD.
CNS Biopharma Need Your Help With:
In Vitro Models: 3D Cultures, hIPSCs & brain organoids to recapitulate the complexities of ALS pathology including TDP43 pathology, and disease heterogeneity, to ensure smoother translation of preclinical research to the clinic
Clinical CROs: Diligent and efficient services as trusted and reliable partners sought by companies for trial design and program management. Establish how you build market trust and expand your customer base through streamlined and timely services
In vivo models & Preclinical CROs: including TDP43, and C9orf72 rodent models for translational research, to better recapitulate the breadth of ALS pathology and predict efficacy in humans
Biomarker Discovery: largescale biomarker discovery platforms for early ID of novel biomarkers through comprehensive proteomic profiling
Genomic and Proteomic Solutions: including sequencing, genotyping and protein quantification
Diagnostic Tests: high sensitivity plasma and CSF assays for ALS for NFL and TDP43
Drug Discovery: high throughput AI & ML driven engines to support data-driven drug discovery for ALS
And More!
Why Partner?
Whether you're aiming to secure new partnerships, showcase your innovations, or grow your influence, there are unparalleled opportunities to…
Present Your Science: Take the stage to share your latest advancements and position your organization as a key player in ALS innovation.
Exclusive Networking: Host private meetings, roundtable discussions, or sponsored networking sessions with key decision-makers in ALS research
Maximized Visibility: Benefit from logo placements, digital promotions, and program features that keep your organization front and center
Who Will You Meet?
